Sunshine Biopharma Inc. Held Annual Shareholder Meeting
I'm PortAI, I can summarize articles.
Sunshine Biopharma Inc. held its annual shareholder meeting on December 11, 2025. Directors elected include Dr. Steve N. Slilaty, Mr. Camille Sebaaly, Dr. Rabi Kiderchah, Mr. David Natan, and Dr. Andrew Keller. Stockholders ratified M&K CPAS, PLLC as the independent accounting firm for 2025. An amendment to the 2023 Equity Incentive Plan to increase authorized shares to 683,000 was approved.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments